Cytokinetics | CYTK - Koszty Operacyjne





Koszty Operacyjne Zmiana Data
Acadia Pharmaceuticals USD 270.57M 450K 2026-09
Amgen USD 5.69B 6B 2026-09
Arca Biopharma USD 36.43M 2M 2026-03
Bayer EUR 9.92B 121M 2026-09
Biogen USD 2.32B 663.6M 2026-09
Brainstorm Cell Therapeutics USD 2.05M 198K 2026-03
Bristol-Myers Squibb USD 23.4B 1.08B 2026-09
Capricor Therapeutics USD 29.16M 2.87M 2025-12
Cytokinetics USD 214.64M 6.85M 2026-09
Eisai JPY 209.6B 6.14B 2026-06
Eli Lilly USD 10.52B 496M 2026-06
Exelixis USD 390.27M 10M 2026-09
Geron USD 54.46M 15.67M 2026-09
Halozyme Therapeutics USD 198M 4.66M 2026-09
Ionis Pharmaceuticals USD 370.24M 6.24M 2026-06
Ligand Pharmaceuticals USD 94.5M 39.4M 2026-09
Merck USD 10.75B 5.02B 2026-09
Novartis USD 9.88B 325M 2026-09
Pfizer USD 89B 3.81B 2026-09
Regeneron Pharmaceuticals USD 33.5B 1.79B 2026-09
Roche Holding CHF 18.9B 2.12B 2026-06
Sanofi EUR 10.51B 598M 2026-09